Compugen Ltd. Stock
Price
Target price
€1.37
€1.37
-2.860%
-0.04
-2.860%
€3.92
11.12.25 / Tradegate
WKN: 553001 / Symbol: CGEN / Name: Compugen / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Compugen Ltd. Stock
A loss of -2.860% shows a downward development for Compugen Ltd..
The community is currently still undecided about Compugen Ltd. with 1 Buy predictions and 0 Sell predictions.
With a target price of 3 € there is potential for a 119.3% increase which would mean more than doubling the current price of 1.37 € for Compugen Ltd..
Pros and Cons of Compugen Ltd. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Compugen Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Compugen Ltd. | -2.860% | 5.069% | -6.173% | -10.236% | -9.524% | 58.150% | - |
| Protalix Biotherapeutics Inc. | -4.580% | 4.167% | -6.250% | -12.306% | -15.062% | 38.122% | -47.552% |
| Chromadex Corp | -1.800% | 0.000% | -4.310% | -4.310% | 7.767% | 271.113% | 32.143% |
| Intellia Therapeutics Inc | 0.050% | -6.699% | 2.753% | -37.471% | -32.354% | -78.838% | -82.083% |
Comments
Compugen Ltd. (NASDAQ: CGEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
